Alaunos Therapeutics, Inc. (TCRT)
1.855
+0.02
(+0.82%)
USD |
NASDAQ |
Nov 06, 10:26
Alaunos Therapeutics Net Income (Quarterly) : -0.952M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.952M |
| March 31, 2026 | -1.006M |
| December 31, 2025 | -0.893M |
| September 30, 2025 | -1.159M |
| June 30, 2025 | -1.051M |
| March 31, 2025 | -1.073M |
| December 31, 2024 | -0.742M |
| September 30, 2024 | -1.127M |
| June 30, 2024 | -1.129M |
| March 31, 2024 | -1.682M |
| December 31, 2023 | -7.843M |
| September 30, 2023 | -8.476M |
| June 30, 2023 | -8.773M |
| March 31, 2023 | -10.05M |
| December 31, 2022 | -9.159M |
| September 30, 2022 | -8.851M |
| June 30, 2022 | -9.932M |
| March 31, 2022 | -9.788M |
| December 31, 2021 | -11.79M |
| September 30, 2021 | -22.73M |
| June 30, 2021 | -22.67M |
| March 31, 2021 | -21.55M |
| December 31, 2020 | -22.77M |
| September 30, 2020 | -20.32M |
| June 30, 2020 | -18.60M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.29M |
| December 31, 2019 | -15.75M |
| September 30, 2019 | -74.00M |
| June 30, 2019 | -14.62M |
| March 31, 2019 | -13.43M |
| December 31, 2018 | -12.48M |
| September 30, 2018 | -12.58M |
| June 30, 2018 | -12.03M |
| March 31, 2018 | -16.02M |
| December 31, 2017 | -13.27M |
| September 30, 2017 | -12.70M |
| June 30, 2017 | -12.86M |
| March 31, 2017 | -15.49M |
| December 31, 2016 | -11.22M |
| September 30, 2016 | -10.85M |
| June 30, 2016 | -131.20M |
| March 31, 2016 | -12.02M |
| December 31, 2015 | -9.476M |
| September 30, 2015 | -18.17M |
| June 30, 2015 | -14.21M |
| March 31, 2015 | -78.23M |
| December 31, 2014 | -10.40M |
| September 30, 2014 | -6.093M |
| June 30, 2014 | -5.576M |
| March 31, 2014 | -9.711M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.952M |
| EPS Diluted (Quarterly) | -0.4063 |
| Enterprise Value | 4.450M |
| Earnings Yield | -105.0% |
| Normalized Earnings Yield | -105.02 |